KMC Speciality Hospitals (India) Limited (BOM:524520)
India
· Delayed Price · Currency is INR 69.50
-0.36 (-0.52%)
At close: Apr 22, 2025
BOM:524520 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,156 | 1,772 | 1,558 | 1,361 | 1,026 | 961.8 | Upgrade
|
| Revenue | 2,156 | 1,772 | 1,558 | 1,361 | 1,026 | 961.8 | Upgrade
|
| Revenue Growth (YoY) | 24.33% | 13.75% | 14.46% | 32.58% | 6.71% | 16.92% | Upgrade
|
| Cost of Revenue | 858.89 | 688.08 | 585.69 | 524.46 | 415.09 | 385.34 | Upgrade
|
| Gross Profit | 1,297 | 1,084 | 971.87 | 836.27 | 611.28 | 576.46 | Upgrade
|
| Selling, General & Admin | 35.27 | 35.27 | 35.42 | 29.13 | 18.01 | 29.52 | Upgrade
|
| Other Operating Expenses | 720.59 | 566.32 | 517.64 | 432.11 | 353.4 | 334.03 | Upgrade
|
| Operating Expenses | 927.18 | 699.96 | 632.92 | 528.5 | 439.27 | 414.94 | Upgrade
|
| Operating Income | 369.47 | 383.71 | 338.95 | 307.77 | 172.01 | 161.52 | Upgrade
|
| Interest Expense | -76.01 | -11.64 | -8.11 | -6.96 | -9.52 | -8.61 | Upgrade
|
| Interest & Investment Income | 20.33 | 20.33 | 17.67 | 12.45 | 8.92 | 9.34 | Upgrade
|
| Other Non Operating Income (Expenses) | 8.45 | 13.38 | 12.32 | 7.43 | 8.85 | 4.69 | Upgrade
|
| EBT Excluding Unusual Items | 322.24 | 405.78 | 360.83 | 320.69 | 180.25 | 166.95 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.2 | -0.2 | -0.93 | 0.29 | 0.19 | - | Upgrade
|
| Pretax Income | 322.04 | 405.58 | 359.9 | 320.98 | 180.44 | 166.95 | Upgrade
|
| Income Tax Expense | 82.13 | 101.79 | 93.02 | 83.72 | 52.64 | 49.52 | Upgrade
|
| Net Income | 239.91 | 303.79 | 266.88 | 237.26 | 127.79 | 117.43 | Upgrade
|
| Net Income to Common | 239.91 | 303.79 | 266.88 | 237.26 | 127.79 | 117.43 | Upgrade
|
| Net Income Growth | -21.47% | 13.83% | 12.49% | 85.66% | 8.83% | 36.42% | Upgrade
|
| Shares Outstanding (Basic) | 163 | 163 | 163 | 163 | 163 | 163 | Upgrade
|
| Shares Outstanding (Diluted) | 163 | 163 | 163 | 163 | 163 | 163 | Upgrade
|
| EPS (Basic) | 1.47 | 1.86 | 1.64 | 1.45 | 0.78 | 0.72 | Upgrade
|
| EPS (Diluted) | 1.47 | 1.86 | 1.64 | 1.45 | 0.78 | 0.72 | Upgrade
|
| EPS Growth | -21.64% | 13.66% | 12.49% | 85.66% | 8.83% | 36.42% | Upgrade
|
| Free Cash Flow | - | -368.51 | -117.89 | 156.4 | -152.52 | 72.34 | Upgrade
|
| Free Cash Flow Per Share | - | -2.26 | -0.72 | 0.96 | -0.94 | 0.44 | Upgrade
|
| Gross Margin | 60.15% | 61.16% | 62.40% | 61.46% | 59.56% | 59.94% | Upgrade
|
| Operating Margin | 17.14% | 21.66% | 21.76% | 22.62% | 16.76% | 16.79% | Upgrade
|
| Profit Margin | 11.13% | 17.15% | 17.14% | 17.44% | 12.45% | 12.21% | Upgrade
|
| Free Cash Flow Margin | - | -20.80% | -7.57% | 11.49% | -14.86% | 7.52% | Upgrade
|
| EBITDA | 455.36 | 461.36 | 405.62 | 364 | 226.24 | 206.16 | Upgrade
|
| EBITDA Margin | 21.13% | 26.04% | 26.04% | 26.75% | 22.04% | 21.44% | Upgrade
|
| D&A For EBITDA | 85.89 | 77.65 | 66.67 | 56.24 | 54.24 | 44.64 | Upgrade
|
| EBIT | 369.47 | 383.71 | 338.95 | 307.77 | 172.01 | 161.52 | Upgrade
|
| EBIT Margin | 17.14% | 21.66% | 21.76% | 22.62% | 16.76% | 16.79% | Upgrade
|
| Effective Tax Rate | 25.50% | 25.10% | 25.85% | 26.08% | 29.18% | 29.66% | Upgrade
|
| Revenue as Reported | 2,186 | 1,807 | 1,589 | 1,382 | 1,046 | 975.97 | Upgrade
|
| Advertising Expenses | - | 28.85 | 27.4 | 22.35 | 12.47 | 25.37 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.